CD8+ T cells are the effectors of the contact dermatitis induced by urushiol in mice and are regulated by CD4+ T cells

International Archives of Allergy and Immunology

Volumn 117, Issue 3, 1998, Pages 194-201

  López, Carolina B ^a   Kalergis, Alexis M ^a   Becker, María Inés ^a   Garbarino, Juan A ^b   De Ioannes, Alfredo E ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b Laboratorio de Química Inorgánica Instituto de Química Campus Curauma   (Chile)

Author keywords

Contact dermatitis; Hypersensitivity; T cell subpopulation; Urushiols

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; URUSHIOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTACT DERMATITIS; FEMALE; HELPER CELL; IMMUNOREGULATION; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SECONDARY IMMUNE RESPONSE; T LYMPHOCYTE;

LITHRAEA CAUSTICA;

EID: 0031729757     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024010     Document Type: Article

References (42)

1. Benezra C, Dupuis G: L'allergie de contact. Recherche 1983;14:1062-1072.
2. Benezra C: Molecular recognition in allergic-contact dermatitis to natural products. Pure Apple Chem 1990;62:1251-1258
3. Meltzer M, Nacy C: Delayed-type hypersensitivity and the induction of activated, cytotoxic macrophages; in Paul WE (ed): Fundamental Immunology. New York, Raven Press, 1989. p 765.
4. Kalish R: Recent developments in the pathogenesis of allergic contact dermatitis. Arch Dermatol 1991;127:1558-1563.
5. Harlow W: Poison ivy and Poison sumac. New-York State College of Forestry at Syracuse 1990, vol. 22, p 4.
6. Dawson CR: Final Report on the Chemistry of poison ivy (Contract Nr PH-43-64-76), US Department of Commerce, National Technical Information Service, Springfield. 1973.
7. Gambaro V, Chamy M, von Brand E, Garbarino J: 3-(pentadec-10-enyl)-catechol. a new allergenic compound from Lithreae caustica (Anacardiaceae). Planta Med 1986;15:20-22.
8. Baer H, Watkins R, Bowser R: Delayed contact sensitivity to catechols and resorcinols. The relationship of structure and immunization procedure to sensitizing capacity. Inmunochemistry 1966;3:479-485.
9. Byers V, Castagnoli N, Epstein W: In vitro studies of poison oak immunity. II. Effect of urushiol analogues on the human in vitro response. J Clin Invest 1979;64:1449-1456.
10. Johnson R, Baer H, Kirkpatrick C, Dawson C, Khurana R: Comparison of the contact allergenicity of the four pentadecylcatechols derived from poison ivy urushiol in human subjects. J Allergy Clin Immunol 1972;49:27-35.
11. Kalergis A, López CB, Becker MI, Díaz MI, Sein J, Garbarino JA, De Ioannes AE: Modulation of fatty acid oxidation alters contact hypersensitivity to urushiols: Role of aliphatic chain beta-oxidation in processing and activation of urushiols. J Invest Dermatol 1997;108: 57-61.
12. Cher D, Mosmann T: Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol 1987;138:3688-3694.
13. Liew F: Regulation of delayed-type hypersensitivity to pathogens and alloantigens. Immunol Today 1982;3:18-23.
14. Waldorf H, Walsh LS, Murphy G: Early cellular events in evolving cutaneous delayed hypersensitivity in humans. Am J Pathol 1991; 138:477-486.
15. Gocinski B, Tigelaar R: Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 1990;144:4121-4128.
16. Bour H, Peyron E, Gaucherand M, Garrigue J, Desvignes C, Kaiserlian D, Revillard J, Nicolas J: Major histocompatibility complex class I-Restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur J Immunol 1995;25:3006-3010.
17. Kalish R, Wood J, LaPorte A: Processing of urushiol (poison ivy) hapten by both endogenous and exogenous pathways for presentation to T cells in vitro. J Clin Invest 1994;93: 2039-2047.
18. Laemmli EK: Cleavage of structural proteins the assembly of the head of hacteriophage T4. Nature 1970;227:680-685.
19. Harlow E, Lane D: Antibodies: Laboratory Manual, New York, Cold Spring Harbor Laboratory, 1988, p 392.
20. Jennings S, Bonneau R, Smith P, Wolcott R, Chervenak R: CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CDS-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice. Cell Immunol 1991;133: 234-252.
21. Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldmann H: Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 1984;312:548-551.
22. Rice J, Bucy R: Differences in the degree of depletion, rate of recovery, and the preferential elimination of naive CD4+ T cells by anti-CD4 monoclonal antibody (GK1.5) in young and aged mice. J Immunol 1995;154:6644-6654.
23. Bosma G, Custer R, Bosma M: A severe combined immunodeficiency mutation in the mouse. Nature 1983;301:527-530.
24. Bosma M, Carroll A: The SCID mouse mutant: Definition, characterization, and potential uses. Annu Rev Immunol 1991;9:323-350.
25. Dorshkind K, Pollack S, Bosma M, Phillips R: Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J Immunol 1985;134:3798-3810.
26. Roelandt L, Todaro A, Thome JP, Kremers P: Effects of PCBs (Aroclor 1254) on cytochrome-P450 expression and monooxygenase activities incultured foetal rat hepatocytes. Toxicology 1995;98:95-103.
27. Pairon JC, Trabelsi N, Buard A, Fleury-Feith J, Bacheler CM, Poron F, Beaune P, Brochard P, Laurent P: Cell localization and regulation of expression of cytochrome P450 1A1 and 2B1 in rat lung after induction with 3-methyl-cholanthrene using mRNA hybridization and immunohistochemistry. Am J Resp Cell Molec Biol 1994;11:386-396.
28. Burke MD, Thompson S, Weaver RJ, Walf CR, Mayer RT: Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol 1994;48:923-936.
29. Jugert FK, Agarwal R, Kuhn A, Bickers DR, Merk HF, Mukhtar H: Multiple cytochrome P450 isozymes in murine skin: induction of P450 1A, 2B, 2E, and 3A by dexamethasone, J Invest Dermatol 1994;102:970-975.
30. Allison J, Havran W: The immunobiology of T cells with invariant gamma delta antigen receptors. Annu Rev Immunol 1991;9:679-705.
31. Kaminski M, Bergstresser P, Takashima A: In vivo activation of mouse dendritic epidermal T cells in sites of contact dermatitis. Eur J Immunol 1993;23:1715-1718.
32. Askenase PW, Szczepanik M, Ptak M, Paliwal V, Ptak W: Gamma delta T cells in normal spleen assist immunized alpha beta T cells in the adoptive cell transfer of contact sensitivity. Effect of Bordetella pertussis cyclophosphamide. and antibodies to determinants on suppressor cells. J Immunol 1995;154:3644-3653.
33. Huber H, Descossy P, van Brandwijk R, Knop J: Activation of murine epidermal TCR-gamma delta+ T cells by keratinocytes treated with contact sensitizers. J Immunol 1995;155: 2888-2894.
34. Matsuda H, Ushio H, Geba GP, Askenase PW: Human platelets can initiate T-cell-dependent contact sensitivity through local serotonin release mediated by IgE antibodies. J Immunol 1997;158:2891-2894.
35. Tsuji RF, Geba GP, Wang Y, Kawamoto K, Askenase PW: Required early complement activation of local CS-dependent chemotactic activity, and late T cell interferon gamma: A possible initiating role of B cells. J Exp Med 1997; 186:1015-1026.
36. Xu H, Dilulio N, Fairchild R: T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: Interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (II) 4/II-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 1996; 183:1001-1012.
37. Dilulio N, Xu H, Fairchild R: Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response Eur J Immunol 1996;26:2606-2612.
38. Ushio H, Tsuji RF, Szczepanik M, Kawamoto K, Matsuda H, Askenase PW: IL-12 reverses established antigen-specific tolerance of contact sensitivity by affecting costimulatory molecules B71 (CD80) and B7-2 (CD86). J Immunol 1998;160:2080-2088.
39. Gelber C, Gemmell L, McAteer D, Homola M, Swain P, Liu A Wilson J, Gefter M: Down-regulation of poison ivy/oak-induced contact sensitivity by treatment with a class II MHC binding peptide: Hapten conjugate. J Immunol 1997;158:2425-2434.
40. van der Kwast TH, Benner R: The involvement of T1 and T2 lymphocytes in primary and secondary delayed type hypersensitivity responsiveness. Ann Immunol 1977;128:1019-1024.
41. Hahn H, Kaufmann SH, Falkenberg F, Chahinin M, Horn W: Peritoneal exudate T lymphocytes with specificity to sheep red blood cells. II. Inflammatory helper T cells and effector T cells in mice with delayed-type hypersensitivity and in suppressed mice. Immunology 1979;38:51-55.
42. Tamura S, Kikuta K, Kobayashi T, Sato Y, Sato H: Studies on primed precursors of effector T cells involved in delayed-type hypersensitivity to shepp red blood cells in mice. Cell Immunol 1987;108:120-131.